Lack of sporicidal activity in diallyl-disulphide-oxide and a nanotechnology-product for sterilizing medical and dental instruments
AbstractObjective: To evaluate sporicidal activity in products commercially available for sterilization of medical and dental instruments. Method: In simulated use and under worst-case scenario conditions, Bacillus atrophaeus spores were suspended in diallyl disulphide oxide (DDO), a nanotechnology product (NANO) or three SOW solutions. After 6 hour exposure, the spore suspensions were filtered, washed and incubated. Results: The DDO and NANO formulations evaluated lack sporicidal activity and are inadequate to sterilize instruments. The three SOW solutions evaluated are sporicidal but their activities are inhibited by protein. Their respective sterilization contact times remain to be determined. Conclusions: The results identify formulations that pose a risk to patients, and unveil failures in the regulatory evaluation of products. The absence of science-based regulatory standards results in the commercialization of unsafe products without the required sporicidal activity. To strengthen national and local health systems, the international infection prevention community must critically review the regulatory expectations for sporicidal products and disseminate information on the basics of antimicrobial effectiveness testing.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.